PPARGC1A and colorectal carcinoma: Chen et al. found that the natural compound Isoliquiritigenin (ISL), as an inhibitor of PGC-1α, targeted ABCA1 and reduced CRC metastasis by inhibiting EMT (W. Chen W et al., 2023).